Pfizer’s Deal on Generic Viagra Shows Treatment Changes
This article is for subscribers only.
Fifteen years after Pfizer Inc.’s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017.
Pfizer’s little blue pills, which generally cost about $15 each, replaced treatment that included penile injections, pumps and surgery. It will be produced generically, probably for a far lower cost, after Israel-based Teva Pharmaceuticals Industries Ltd. reached a legal settlement to sell a copy of the drug, whose chemical name is sildenafil citrate, more than two years earlier than expected.